1. Which of the following BEST describes regular human insulin compared with the rapid-acting human insulin analogs?

2. What is the recommended starting dose schedule for rapid-acting insulin?

3. KS is an 85-year-old long-term care resident with type 2 diabetes (T2DM) who is treated with basal insulin plus once-daily rapid-acting insulin. Although she has almost no history of hypoglycemic episodes, she has recently begun to experience mild hypoglycemia 2 to 3 times per week. Her hypoglycemia appears to be related to her T2DM treatment as other potential causes of been ruled out. What strategy would you recommend to address her hypoglycemia?

4. According to the Centers for Medicare and Medicaid Services, approximately how many hospital readmissions are potentially avoidable by improving multidisciplinary communication and collaboration during care transitions?

5. LM is an 87-year-old long-term care (LTC) resident with type 2 diabetes (T2DM) and chronic obstructive pulmonary disease. His T2DM is currently managed with basal insulin and once-daily rapid-acting mealtime insulin. He was hospitalized last week for pneumonia, and today he is being discharged from the hospital and transferred back to his LTC facility. He was discharged and prescribed a fluoroquinolone antibiotic, but his insulin regimen was not changed. Which of the following actions is needed at this time?

« Return to Activity